Charles Schwab Investment Management Inc Magenta Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$1.26 - $2.09 $34,484 - $57,201
27,369 New
27,369 $39,000
Q2 2022

Aug 15, 2022
SELL
$0.97 - $3.08 $86,470 - $274,566
-89,145 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$2.55 - $5.23 $15,526 - $31,845
6,089 Added 7.33%
89,145 $259,000
Q3 2021

Nov 16, 2021
BUY
$6.07 - $9.89 $50,253 - $81,879
8,279 Added 11.07%
83,056 $605,000
Q2 2021

Aug 16, 2021
BUY
$9.76 - $14.15 $196,410 - $284,754
20,124 Added 36.82%
74,777 $732,000
Q1 2021

May 17, 2021
BUY
$7.66 - $13.38 $29,314 - $51,205
3,827 Added 7.53%
54,653 $648,000
Q3 2020

Nov 13, 2020
BUY
$6.52 - $8.94 $41,643 - $57,099
6,387 Added 14.37%
50,826 $346,000
Q2 2020

Aug 14, 2020
SELL
$6.18 - $10.76 $24,893 - $43,341
-4,028 Reduced 8.31%
44,439 $334,000
Q1 2020

May 15, 2020
BUY
$6.03 - $15.24 $102 - $259
17 Added 0.04%
48,467 $305,000
Q3 2019

Nov 08, 2019
BUY
$9.63 - $14.0 $50,538 - $73,472
5,248 Added 12.15%
48,450 $498,000
Q2 2019

Aug 09, 2019
BUY
$13.4 - $17.67 $150,147 - $197,992
11,205 Added 35.02%
43,202 $638,000
Q1 2019

May 14, 2019
BUY
$5.7 - $19.7 $108,505 - $375,009
19,036 Added 146.87%
31,997 $527,000
Q4 2018

Feb 14, 2019
BUY
$5.57 - $11.65 $72,192 - $150,995
12,961 New
12,961 $74,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email